Terapias dirigidas en combinación con hormonoterapia en cáncer de mama avanzado HER2- negativo - page 43



A Phase Ib/II Randomized Study of BI 836845 in

Combination with Exemestane and Everolimus Versus

Exemestane and Everolimus Alone in Women with Locally

Advanced or Metastatic Breast Cancer

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,33,34,35,36,37,38,39,40,41,42 44,45